08 jun: Det bølgende hus
10 jun: Overskud i APM´s containerforretning
08-06-2012 23:55:00

J&J to Record $600 Million Charge in 2Q

Relateret indhold

Johnson & Johnson (JNJ) said it plans to record a special charge of roughly $600 million in its second quarter to increase its accrual for potential legal settlements, as it has faced a series of lawsuits over accusations of bribery and improper drug-marketing practices.

The company said the settlement payments stem for a series of outstanding civil cases that involve its drugs Risperdal, Invega and Natrecor, as well as nursing-home pharmacy operator Omnicare Inc. (OCR).

The health-care products company has faced lawsuits related to alleged off-label promotion of its antipsychotic treatment Risperdal, which was once J&J's top-selling drug before generic copycats hit the market, as well as legal challenges over off-label promotion of another schizophrenia treatment, Invega, and the heart-failure drug Natrecor.

Furthermore, the federal government is suing J&J, accusing it of paying kickbacks to induce Omnicare to encourage use of Risperdal and other J&J drugs.

In addition, J&J has dealt with state lawsuits regarding its promotion of Risperdal, including an Arkansas case in which the company in April was ordered to pay $1.2 billion after a jury found that J&J's past marketing of the drug violated the state's consumer-protection laws. J&J previously was ordered to pay $327 million in a South Carolina case and $258 million in Louisiana. The company is appealing all three cases.

In January, J&J agreed to settle a Texas case for $158 million.

Meanwhile, the company agreed to pay an $85 million fine in a criminal case regarding off-label marketing of Natrecor. Parallel civil litigation still hasn't been settled.

The company in April said its first-quarter earnings rose on a foreign-exchange-related gain tied to an acquisition and lower expenses.

Shares closed Friday at $62.98 and were unchanged after hours. The stock is down 4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

(END) Dow Jones Newswires

June 08, 2012 17:55 ET (21:55 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Mærsk: Spotrater på Asien-Europa falder for fjerde uge i træk

22-09-2017 15:06:05
Spotpriserne for containerfragt på de vigtige ruter mellem Asien og Europa faldt i denne uge med 3,9 pct. til 734 dollar per tyvefodscontainer (teu).Det skriver branchemediet Journal of Commerce, der henviser til data fra Shanghai Shipping Exchange.Det er fjerde uge på stribe, at containerraterne falder på ruten, der er A.P. Møller-Mærsks største. Siden den 1. juli er spotraten faldet næsten 300 d..

Mærsk-rival sender seks rigge på pension og tager milliardnedskrivning

22-09-2017 13:19:28
Det Schweiz-baserede rigselskab Transocean, der arbejder i samme branche som Maersk Drilling, har besluttet at sende seks borerigge på pension og tager på den baggrund en nedskrivning på 1,4 mia. dollar - svarende til 8,8 mia. kr.Det skriver Bloomberg News.De seks rigge har ikke været i drift på det seneste, men har været kategoriseret som "cold-stacked", hvilket vil sige, at de ikke har været bem..

Aktier/åbning: ALK med negativt fortegn mens bilforhandler drøner frem

22-09-2017 09:21:51
ALK-Abelló, der udvikler allergivacciner, falder med 2,2 pct. til 978,50 kr. i de første handler fredag morgen, på en dag hvor aktiemarkedet generelt åbner i rødt.De franske myndigheder har givet vaccineselskabet påbud om nødvendige opgraderinger af kvalitetssystemet på fabrikken i Vandeuil, Frankrig, hvor der lukkes ned for dele af produktionen midlertidigt. Produkterne, der er omfattet af nedluk..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

Johnson & Johnson 131,39 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
24. september 2017 10:31:14
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170921.1 - EUROWEB5 - 2017-09-24 10:31:14 - 2017-09-24 10:31:14 - 1 - Website: OKAY